-
1
-
-
85033529904
-
-
Japanese source
-
-
-
-
2
-
-
85033511104
-
-
Japanese source
-
-
-
-
3
-
-
53249089502
-
Uber das operationsrisks bei Hemophilia
-
Friedrich H : Uber das operationsrisks bei Hemophilia. Der Chirurg 7 : 73-78, 1935
-
(1935)
Der Chirurg
, vol.7
, pp. 73-78
-
-
Friedrich, H.1
-
4
-
-
0022572919
-
Surgery in hemophilia and related disorders
-
Kitchens CS : Surgery in hemophilia and related disorders. Medicine 65 : 34-45, 1986
-
(1986)
Medicine
, vol.65
, pp. 34-45
-
-
Kitchens, C.S.1
-
5
-
-
0004485874
-
Treatment of hemophilia A with human antihemophilic globlin
-
Blomback M, Erik JJ, Nilsson IM : Treatment of hemophilia A with human antihemophilic globlin. Acta Med Scand 161 : 301-321, 1958
-
(1958)
Acta Med Scand
, vol.161
, pp. 301-321
-
-
Blomback, M.1
Erik, J.J.2
Nilsson, I.M.3
-
6
-
-
0013856638
-
Production of highpotency concentrates of antihemopholic globlin in a closed-bag system
-
Pool GG, Schannon AE : Production of highpotency concentrates of antihemopholic globlin in a closed-bag system. N Engl J Med 273 : 1443-1447, 1965
-
(1965)
N Engl J Med
, vol.273
, pp. 1443-1447
-
-
Pool, G.G.1
Schannon, A.E.2
-
8
-
-
53249096729
-
-
A 1. Med Postgrad 19 : 547-553, 1981
-
(1981)
Med Postgrad
, vol.19
, pp. 547-553
-
-
-
9
-
-
85033534445
-
-
Japanese source
-
-
-
-
10
-
-
85033535717
-
-
Japanese source
-
-
-
-
11
-
-
85033539479
-
-
Japanese source
-
-
-
-
12
-
-
85033544971
-
-
Japanese source
-
-
-
-
13
-
-
0025644310
-
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A
-
Schwartz RS, Abildgaard CF, Aledort LM et al : Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. N Engl J Med 323 : 1800-1805, 1990
-
(1990)
N Engl J Med
, vol.323
, pp. 1800-1805
-
-
Schwartz, R.S.1
Abildgaard, C.F.2
Aledort, L.M.3
-
14
-
-
85033531137
-
-
Japanese source
-
-
-
-
15
-
-
0028054670
-
Transmission of Hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses
-
Mannucci PM, Gdovin S, Gringeri A et al : Transmission of Hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. Ann Intern Med 120 : 1-7, 1994
-
(1994)
Ann Intern Med
, vol.120
, pp. 1-7
-
-
Mannucci, P.M.1
Gdovin, S.2
Gringeri, A.3
-
16
-
-
0028110958
-
Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs
-
Grobe-Bley A, Eis-Hubinger AM, Kaiser R etal : Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost 72 : 503-507, 1994
-
(1994)
Thromb Haemost
, vol.72
, pp. 503-507
-
-
Grobe-Bley, A.1
Eis-Hubinger, A.M.2
Kaiser, R.3
-
17
-
-
0028000681
-
Identification of transforming growth factorβas a contaminant in factor VIII concentrates: A possible link with immunosuppressive effects in hemophiliacs
-
Wadhwa M, Dilger P, Tubbs J et al : Identification of transforming growth factorβas a contaminant in factor VIII concentrates : A possible link with immunosuppressive effects in hemophiliacs. Blood 84 : 2021-2030, 1994
-
(1994)
Blood
, vol.84
, pp. 2021-2030
-
-
Wadhwa, M.1
Dilger, P.2
Tubbs, J.3
-
18
-
-
0015370493
-
Hemolusis due to anti-A and anti-B infactor VIII preparations
-
Ashenhurst JB, Langehenning PL, Seeler RA et al : Hemolusis due to anti-A and anti-B infactor VIII preparations. Arch Intern Med 130 : 101-103, 1972
-
(1972)
Arch Intern Med
, vol.130
, pp. 101-103
-
-
Ashenhurst, J.B.1
Langehenning, P.L.2
Seeler, R.A.3
-
19
-
-
0028221771
-
Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII
-
Mannucci PM, Brettler DB, Aledort LM et al : Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. Blood 83 : 1958-1962, 1994
-
(1994)
Blood
, vol.83
, pp. 1958-1962
-
-
Mannucci, P.M.1
Brettler, D.B.2
Aledort, L.M.3
|